Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy

Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy

US Patent 9782483 · Granted Oct 10, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Serotonin-norepinephrine reuptake inhibitors (SNRIs) and Sigma receptor ligands 2018
1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of op2018
Sigma ligands for use in the prevention and/or treatment of post-operative pain2017
Sigma ligands for use in the prevention and/or treatment of post-operative pain2017
Use of sigma ligands in opioid-induced hyperalgesia2017
Use of sigma ligands in opioid-induced hyperalgesia2017
Use of sigma ligands in diabetes type-2 associated pain2017
Sigma ligands for potentiating the analgesic effect of opioids and opiates in po2017
Sigma ligands for potentiating the analgesic effect of opioids and opiates in po2017
Use of sodium channel blockers for the treatment of neuropathic pain developing 2015
1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of op2014
1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of op2014